| 篇名 | 作者 | 刊名 | 出版年 | 查看 |
|---|
| Esomeprazole-based Helicobacter pylori eradication therapy and the effectof antibiotic resistance: results of three US multicenter, double-blindtrials |
Laine, L.;Fennerty, M.B.;Osato, M.;Sugg M.S, J.;Suchower M.Sc, L.;Probst B.A, P.;Levine, J.G.; |
The American Journal of Gastroenterology |
2000-12-01 |
查看 |
| Comparison of the new PPI esomeprazole, the S-isomer of omeprazole, vsplacebo for the treatment of symptomatic GERD (sGERD) |
Katz, P.O.;Castell, D.O.;Marino, V.;Whipple, J.;Levine, J.G.; |
The American Journal of Gastroenterology |
2000-09-01 |
查看 |
| Esomeprazole open capsule mixed with applesauce is bioequivalent to theintact capsule when administered to healthy volunteers |
Andersson, T.;Magner, D.J.;Patel, J.B.;Rogers, P.;Levine, J.G.; |
The American Journal of Gastroenterology |
2000-09-01 |
查看 |
| Efficacy and safety of esomeprazole compared with omeprazole in GERDpatients with erosive esophagitis: a randomized controlled trial |
Richter, J.E.;Kahrilas, P.J.;Johanson, J.;Maton, P.;Breiter, J.R.;Hwang, C.;Marino, V.;Hamelin, B.;Levine, J.G.;Esomeprazole Study Investigators; |
The American Journal of Gastroenterology |
2001-03-01 |
查看 |
| Budesonide modified release capsules as maintenance treatment in mild tomoderate Crohn's disease |
Hanauer, S.B.;Sandborn, W.J.;Levine, J.G.;Persson, A.;Persson, T.; |
The American Journal of Gastroenterology |
2001-09-01 |
查看 |
| Evidence-based analysis of the benefit of esomeprazole in the treatment oferosive esophagitis (EE) |
Levine*, J.G.;Hwang, C.;Roach, A.;Bjorkman, D.J.; |
The American Journal of Gastroenterology |
2001-09-01 |
查看 |
| Esomeprazole is more effective than lansoprazole for treating daily andnocturnal heartburn in GERD patients with erosive esophagitis (EE) |
Castell*, D.O.;Kahrilas, P.J.;Richter, J.E.;Johnson, D.A.;Vakil, N.B.;Zuckerman, S.;Skammer, W.;Levine, J.G.; |
The American Journal of Gastroenterology |
2001-09-01 |
查看 |
| Esomeprazole provides more effective healing than lansoprazole in GERDpatients with erosive esophagitis (EE) |
Castell*, D.O.;Kahrilas, P.J.;Richter, J.E.;Johnson, D.A.;Vakil, N.B.;Zuckerman, S.;Skammer, W.;Levine, J.G.; |
The American Journal of Gastroenterology |
2001-09-01 |
查看 |
| Esomeprazole vs omeprazole in GERD patients with erosive esophagitis (EE):influence of baseline heartburn severity |
DeVault*, K.R.;Fennerty, M.B.;Hwang, C.;Levine, J.G.; |
The American Journal of Gastroenterology |
2001-09-01 |
查看 |
| Baseline severity of heartburn does not influence resolution of heartburnin patients with endoscopy-negative GERD |
Katz*, P.O.;DeVault, K.R.;Hwang, C.;Levine, J.G.; |
The American Journal of Gastroenterology |
2001-09-01 |
查看 |
| Esomeprazole (40 mg) compared with lansoprazole (30 mg) in the treatment oferosive esophagitis |
Castell, D.O.;Kahrilas, P.J.;Richter, J.E.;Vakil, N.B.;Johnson, D.A.;Zuckerman, S.;Skammer, W.;Levine, J.G.; |
The American Journal of Gastroenterology |
2002-03-01 |
查看 |
| Budesonide CIR capsules (once or twice daily divided-dose) in activeCrohn's disease: a randomized placebo-controlled study in the United States |
Tremaine, W.J.;Hanauer, S.B.;Katz, S.;Winston, B.D.;Levine, J.G.;Persson, T.;Persson, A.;The Budesonide CIR United States Study Group; |
The American Journal of Gastroenterology |
2002-07-01 |
查看 |
| The impact of duration of gerd symptoms on severity of esophagitis andresponse to treatment with esomeprazole or lansoprazole |
Fennerty, M.B.;Zuckerman, S.;Levine, J.G.; |
The American Journal of Gastroenterology |
2002-09-01 |
查看 |
| Influence of symptom duration on baseline severity of erosive esophagitisand response to treatment with esomeprazole or omeprazole |
DeVault, K.R.;Zuckerman, S.;Levine, J.G.; |
The American Journal of Gastroenterology |
2002-09-01 |
查看 |
| Impact of age on baseline severity of esophagitis and heartburn, andsubsequent healing following treatment with esomeprazole or lansoprazole |
Johnson, D.A.;Zuckerman, S.;Levine, J.G.; |
The American Journal of Gastroenterology |
2002-09-01 |
查看 |
| Comparison of the onset of the acid-reducing effect of famotidine/antacidcombination tablets, omeprazole 20 mg, and placebo on gastric pH profilesin healthy volunteers |
Lanza, F.L.;Replogle, A.;Stauffer, L.;Furtek, C.;Levine, J.G.; |
The American Journal of Gastroenterology |
2003-09-01 |
查看 |
|
|
